display:none
Skip to main content

Work with DiMe on an upcoming project

Transforming Alzheimer’s Disease and Related Dementia Research: New Core Digital Clinical Measures


Date/Time

November 14, 2024

Panelists

Moderator

Discussion Topic

Alzheimer’s disease and related dementias (collectively referred to as ADRD) have become a public health epidemic. Globally, ADRD affects 47 million people and the expected growth is staggering, with cases expected to double every 20 years.

Even with the increased number of ADRD cases, progress in using digital technologies in clinical research has been limited, and there’s been very little work done to understand meaningful aspects of health for people with ADRD and care partners.

DATAcc by DiMe, with the inclusive group of global multistakeholder experts, has developed a core set of digital measures for ADRD—a set of patient-centered digital measures that bring together research and treatment innovation and the real-world needs of patients, care partners, and clinicians. These measures focus on what truly matters to people living with ADRD and their care partners, ensuring that clinical trials are designed to reach outcomes that reflect meaningful and tangible benefits.

View the core digital measures

View the recording

View the slides

Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today